September,
30
|
March
31,
|
|||||||
2008
|
2008
|
|||||||
ASSETS
|
||||||||
Current
assets:
|
||||||||
Cash
and cash equivalents
|
$ | 14,017 | $ | 19,271 | ||||
Accounts
receivable, net of allowances for sales returns and doubtful accounts of
$213 and $191 at September 30, 2008 and March 31, 2008,
respectively
|
4,609 | 6,758 | ||||||
Inventories,
net
|
13,690 | 11,056 | ||||||
Prepaid
expenses and other current assets
|
659 | 788 | ||||||
Total
current assets
|
32,975 | 37,873 | ||||||
Property
and equipment, net
|
1,210 | 1,213 | ||||||
Intangible
assets, net
|
3,856 | 903 | ||||||
Other
assets
|
75 | 90 | ||||||
Total
assets
|
$ | 38,116 | $ | 40,079 | ||||
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
||||||||
Current
liabilities:
|
||||||||
Notes
payable and bank lines of credit
|
$ | 6 | $ | 14 | ||||
Accounts
payable
|
602 | 1,469 | ||||||
Accrued
product warranty
|
947 | 1,770 | ||||||
Deferred
revenue
|
260 | 252 | ||||||
Accrued
expenses and other current liabilities
|
1,966 | 3,644 | ||||||
Total
current liabilities
|
3,781 | 7,149 | ||||||
Total
liabilities
|
3,781 | 7,149 | ||||||
Commitments
and contingencies (Note 7)
|
||||||||
Stockholders’
equity:
|
||||||||
Preferred
stock; $0.01 par value; 5,000,000 shares authorized; none issued and
outstanding
|
— | — | ||||||
Common
stock; $0.01 par value; 50,000,000 shares authorized; 8,321,496 and
7,242,736 shares
issued and outstanding at September 30, 2008 and March 31, 2008,
respectively
|
83 | 72 | ||||||
Additional
paid-in capital
|
128,217 | 123,567 | ||||||
Accumulated
other comprehensive income (loss)
|
(412 | ) | (446 | ) | ||||
Accumulated
deficit
|
(93,553 | ) | (90,263 | ) | ||||
Total
stockholders’ equity
|
34,335 | 32,930 | ||||||
Total
liabilities and stockholders’ equity
|
$ | 38,116 | $ | 40,079 | ||||
Three
Months Ended
September
30
|
Six
Months Ended
September
30
|
|||||||||||||||
2008
|
2007
|
2008
|
2007
|
|||||||||||||
Revenue
|
$ | 2,010 | $ | 10,800 | $ | 6,739 | $ | 15,398 | ||||||||
Cost
of sales
|
989 | 6,560 | 3,391 | 9,537 | ||||||||||||
Gross
profit
|
1,021 | 4,240 | 3,348 | 5,861 | ||||||||||||
Operating
expenses:
|
||||||||||||||||
Research
and development expenses
|
1,145 | 1,057 | 2,281 | 1,835 | ||||||||||||
Sales
and marketing expenses
|
839 | 1,279 | 1,682 | 2,285 | ||||||||||||
General
and administrative expenses
|
1,471 | 1,448 | 2,801 | 2,651 | ||||||||||||
Total
operating expenses
|
3,455 | 3,784 | 6,764 | 6,771 | ||||||||||||
Operating
income (loss)
|
(2,434 | ) | 456 | (3,415 | ) | (910 | ) | |||||||||
Other
income (expense), net
|
(65 | ) | 237 | 125 | 964 | |||||||||||
Net
income (loss)
|
$ | (2,499 | ) | $ | 693 | $ | (3,290 | ) | $ | 54 | ||||||
Net
income (loss) per share:
|
||||||||||||||||
Basic
|
$ | (0.34 | ) | $ | 0.10 | $ | (0.45 | ) | $ | 0.01 | ||||||
Diluted
|
$ | (0.34 | ) | $ | 0.10 | $ | (0.45 | ) | $ | 0.01 | ||||||
Shares
used in per share computation:
|
||||||||||||||||
Basic
|
7,339 | 7,119 | 7,338 | 7,111 | ||||||||||||
Diluted
|
7,339 | 7,276 | 7,338 | 7,217 |